These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
Delaware
|
95-4106894
|
|
(State
or other jurisdiction
|
(I.R.S.
Employer Identification No.)
|
|
of
incorporation or organization)
|
|
Large
Accelerated Filer
¨
|
Accelerated
Filer
¨
|
|
|
Non-accelerated
filer
¨
|
Smaller
Reporting Company
x
|
|
Class
|
Outstanding
January 7, 2010
|
|
|
Common
Stock, par value $0.0001 per share
|
50,715,001
shares
|
|
Index
|
Page
No.
|
|||
|
PART
I.
|
FINANCIAL
INFORMATION
|
|||
|
ITEM
1.
|
Financial
Statements (Unaudited)
|
|||
|
Statement
Regarding Financial Information
|
4
|
|||
|
Unaudited
Condensed Consolidated Balance Sheets as of November 30, 2009 and February
28, 2009
|
5
|
|||
|
Unaudited
Condensed Consolidated Statements of Operations for the Three and Nine
Months Ended November 30, 2009 and 2008
|
6
|
|||
|
Unaudited
Condensed Consolidated Statements of Cash Flows for the Nine Months Ended
November 30, 2009 and 2008
|
7
|
|||
|
Notes
to Unaudited Condensed Consolidated Financial Statements
|
8
|
|||
|
ITEM
2.
|
Management's
Discussion and Analysis of Financial Condition and Results of
Operations
|
15
|
||
|
ITEM
4T.
|
Controls
and Procedures
|
19
|
||
|
PART
II.
|
OTHER
INFORMATION
|
|||
|
ITEM
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
20
|
||
|
ITEM
6.
|
Exhibits
|
20
|
||
|
SIGNATURES
AND CERTIFICATIONS
|
21
|
|||
|
As
at November 30, 2009
|
As
at February 28, 2009
|
|||||||
|
ASSETS
|
||||||||
|
Current
assets:
|
||||||||
|
Cash
and cash equivalents
|
$
|
21,224
|
$
|
317,256
|
||||
|
Accounts
receivable, net of allowance for doubtful accounts of
$60,000
|
608,542
|
319,249
|
||||||
|
Current
inventories
|
1,500,000
|
1,500,000
|
||||||
|
Other
current assets
|
363,373
|
255,620
|
||||||
|
Total
current assets
|
2,493,139
|
2,392,125
|
||||||
|
Property,
plant, and equipment, net
|
579,143
|
353,444
|
||||||
|
Non-current
inventories net of allowance for obsolete inventories of $2,544,547 and
$2,425,994
|
2,330,376
|
2,545,978
|
||||||
|
Total
assets
|
$
|
5,402,658
|
$
|
5,291,547
|
||||
|
Current
liabilities:
|
||||||||
|
Accounts
payable
|
$
|
1,350,707
|
$
|
1,075,202
|
||||
|
Current
portion of notes payable, net of debt discount
|
897,500
|
225,000
|
||||||
|
Notes
payable- related party
|
4,400,000
|
1,800,000
|
||||||
|
Customer
advances
|
335,033
|
418,612
|
||||||
|
Accrued
expenses
|
2,018,908
|
1,037,917
|
||||||
|
Total
current liabilities
|
9,002,148
|
4,556,731
|
||||||
|
Convertible
notes payable, net of current portion
|
500,000
|
500,000
|
||||||
|
Total
liabilities
|
9,502,148
|
5,056,731
|
||||||
|
Commitments
and contingencies
|
||||||||
|
Stockholders'
equity (deficit):
|
||||||||
|
Common
stock, $0.0001par value, 75,000,000 and 50,000,000 shares authorized,
49,380,431 and 46,344,470 issued and outstanding at November 30, 2009 and
February 28, 2009
|
4,938
|
4,634
|
||||||
|
Additional
paid-in capital
|
373,416,442
|
364,222,963
|
||||||
|
Subscription receivable
|
(27,416
|
)
|
(27,416
|
)
|
||||
|
Accumulated
deficit
|
(377,493,454
|
)
|
(363,965,365
|
)
|
||||
|
Total
stockholders' equity (deficit)
|
(4,099,490
|
)
|
234,816
|
|||||
|
Total
liabilities and stockholders' equity
|
$
|
5,402,658
|
$
|
5,291,547
|
||||
|
Three
Months
|
Nine
Months
|
||||||||||||||
|
2009
|
2008
|
2009
|
2008
|
||||||||||||
|
Net
Revenues
|
$
|
1,160,577
|
$
|
1,065,172
|
$
|
2,425,383
|
$
|
1,891,157
|
|||||||
|
Cost
of goods sold
|
563,148
|
492,837
|
1,384,184
|
1,276,508
|
|||||||||||
|
Gross
Profit
|
597,429
|
572,335
|
1,041,199
|
614,649
|
|||||||||||
|
Operating
Expenses
|
|||||||||||||||
|
Engineering,
research and development expenses
|
562,082
|
556,779
|
1,626,357
|
1,494,894
|
|||||||||||
|
Selling,
general and administrative expenses
|
1,828,847
|
2,040,489
|
5,560,397
|
5,819,237
|
|||||||||||
|
Stock
option compensation expense
|
162,900
|
73,749
|
6,807,418
|
280,913
|
|||||||||||
|
Total
operating expenses
|
2,553,829
|
2,671,017
|
13,994,172
|
5,785,942
|
|||||||||||
|
Loss
from operations
|
(1,956,400,)
|
(2,098,682)
|
(12,952,973)
|
(5,326,402)
|
|||||||||||
|
Other
income and (expense)
|
|||||||||||||||
|
Interest
expense, net
|
(217,032)
|
(422,306)
|
(553,265)
|
(548,328)
|
|||||||||||
|
Other
income (expense), net
|
-
|
229
|
(21,850)
|
144,003
|
|||||||||||
|
Total
other income (expense)
|
(217,032)
|
(422,078)
|
(575,115)
|
(404,325)
|
|||||||||||
|
Net
Loss
|
$
|
(2,173,432)
|
$
|
(2,520,759)
|
$
|
(13,528,088)
|
$
|
(7,384,720)
|
|||||||
|
Total
basic and diluted loss per share
|
$
|
(0.05)
|
$
|
(0.06)
|
$
|
(0.29)
|
$
|
(0.18)
|
|||||||
|
Weighted
average shares used to
compute
basic and diluted income (loss) per share
|
48,171,882
|
43,011,743
|
47,412,895
|
40,628,425
|
|||||||||||
|
2009
|
2008
|
||||||||||||
|
Cash
flow from operating activities:
|
|||||||||||||
|
Net
Loss
|
$
|
(13,528,088
|
)
|
$
|
(7,384,720
|
)
|
|||||||
|
Adjustments
to reconcile Net loss to net cash used in operating
activities
|
|||||||||||||
|
Depreciation
Expense
|
92,452
|
36,319
|
|||||||||||
|
Issuance
of stock as per employment agreement
|
-
|
100,000
|
|||||||||||
|
Amortization
of debt discount
|
220,289
|
-
|
|||||||||||
|
Beneficial
conversion feature expense
|
-
|
368,900
|
|||||||||||
|
Loss
on settlement of debt
|
22,750
|
-
|
|||||||||||
|
Stock
options and warrants expense
|
6,807,417
|
280,913
|
|||||||||||
|
(Increase)
decrease in:
Accounts
receivable
|
(289,293
|
)
|
304,312
|
||||||||||
|
Inventory
|
343,820
|
269,665
|
|||||||||||
|
Other
current assets and deposit
|
(107,753
|
)
|
9,571
|
||||||||||
|
Increase
(decrease) in:
|
|||||||||||||
|
Accounts
payable, customer deposits and accrued expenses
|
1,291,101
|
741,997
|
|||||||||||
|
Net
cash used in operations
|
(5,147,305)
|
(5,273,043
|
)
|
||||||||||
|
Investing
activities:
|
|||||||||||||
|
Acquisition
of plant and equipment
|
(318,151
|
)
|
(119,211
|
)
|
|||||||||
|
Net
cash used in investing activities
|
(318,151
|
)
|
(119,211
|
)
|
|||||||||
|
Financing
activities:
|
|||||||||||||
|
Issuance
of common stock
|
1,667,496
|
1,877,077
|
|||||||||||
|
Proceeds
from notes payable, net
|
3,407,500
|
1,063,863
|
|||||||||||
|
Collections
on (increase in) subscriptions receivable
|
-
|
245,750
|
|||||||||||
|
Exercise
of warrants
|
94,428
|
2,205,277
|
|||||||||||
|
Net
cash provided by financing activities:
|
5,169,424
|
5,391,966
|
|||||||||||
|
Net
decrease in cash & cash equivalents
|
(296,032
|
)
|
(287)
|
||||||||||
|
Cash
and cash equivalents at beginning of period
|
317,256
|
37,532
|
|||||||||||
|
Cash
and cash equivalents at end of period
|
$
|
21,224
|
$
|
37,245
|
|||||||||
|
Supplemental
disclosures of cash flow information
|
|||||||||||||
|
Cash
paid during the period for:
|
|||||||||||||
|
Interest
|
$
|
26,088
|
$
|
120,601
|
|||||||||
|
Income
taxes
|
$
|
-
|
$
|
-
|
|||||||||
|
Buildings
|
40
years
|
|
Machinery
and equipment
|
5
to 10 years
|
|
Furniture
and fixtures
|
7
years
|
|
November
30, 2009
|
February
28, 2009
|
|||||||
|
Raw
materials
|
$
|
2,835,998
|
$
|
2,642,833
|
||||
|
Finished
goods
|
3,538,925
|
3,829,139
|
||||||
|
Reserved
for potential product obsolescence
|
(2,390,088
|
)
|
(2,271,535
|
)
|
||||
|
3,984,835
|
4,200,437
|
|||||||
|
Non-current
portion
|
(2,330,376
|
)
|
(2,545,978
|
)
|
||||
|
Discount
on long term inventory
|
(154,459
|
)
|
(154,459
|
)
|
||||
|
Current
portion
|
$
|
1,500,000
|
$
|
1,500,000
|
||||
|
November
30, 2009
|
February
28, 2009
|
|||||||
|
Machinery
and equipment
|
$
|
1,060,519
|
$
|
1,054,422
|
||||
|
Furniture
and fixtures
|
1,468,603
|
1,438,312
|
||||||
|
Leasehold
Improvements
|
481,887
|
200,124
|
||||||
|
3,011,009
|
2,692,858
|
|||||||
|
Less
accumulated depreciation and amortization
|
2,431,866
|
2,339,414
|
||||||
|
Property,
plant and equipment, net
|
$
|
579,143
|
$
|
353,444
|
||||
|
November
30, 2009
|
February
28, 2009
|
|||||||
|
Accrued
payroll and related expenses
|
$
|
1,609,726
|
$
|
904,849
|
||||
|
Other
|
409,182
|
133,068
|
||||||
|
Total
|
$
|
2,018,908
|
$
|
1,037,917
|
||||
|
November
30, 2009
|
February
28, 2009
|
|||||||
|
Demand
notes payable (a)
|
$
|
140,000
|
$
|
225,000
|
||||
|
Convertible
notes payable (b)
|
1,257,500
|
500,000
|
||||||
|
1,397,500
|
725,000
|
|||||||
|
Less:
Current portion
|
897,500
|
225,000
|
||||||
|
Long-term
portion
|
$
|
500,000
|
$
|
500,000
|
||||
|
|
(a)
|
Consists
of one demand note payable, with interest at an annual rate of 10%, on
which $5,857 in interest was accrued during the nine months ended November
30, 2009, and one demand note with an original balance of $140,000 and a
remaining balance of $90,000 with a flat interest fee of $10,000, which
has already been paid. During the nine month period ended November 30,
2009, the Company settled $35,000 of the notes in 58,333 shares of the
common stock of the Company. The Company recorded a loss on settlement
of debt of $22,750 on the partial
settlement.
|
|
|
(b)
|
Consists
of a convertible note payable totaling $500,000, bearing interest at a
rate of 7%, due in 2013. The note is convertible into our common stock at
a price of $3.00 per share. The Company paid interest of $26,088 on the
note during the nine months ended November 30, 2009. In April 2009, the
Company arranged a debt financing aggregating $192,500 from unrelated
parties in exchange for the issuance of 120 day 10% secured convertible
promissory notes and 30,800 warrants at an exercise price of $1.25 for the
first year. The performance of the notes is secured by all the inventory
of the Company specifically pertaining to the WePower purchase order
including all the proceeds arising from the sale or lease of all or any
part thereof. The notes are convertible into our common stock at a price
of $0.75 per share. The Company accrued interest of $11,732 on the notes
during the nine months ended November 30, 2009. Also consists of six
convertible notes entered into during the second quarter of fiscal 2010
totaling $565,000. The notes carry an interest rate of 10%, are for a term
of 180 days, and are convertible into common stock of the company at $0.75
per share. The company accrued interest of $26,211 on the notes during the
nine months ended November 30,
2009.
|
|
Year
Ending February 28,
|
||||
|
2010
|
$
|
897,500
|
||
|
2011
|
-
|
|||
|
2012
|
-
|
|||
|
2013
|
500,000
|
|||
|
Total
|
$
|
1,397,500
|
||
|
2006
Plan
|
|||||||
|
Weighted-Average
Exercise Price
|
Aggregate
Intrinsic Value
|
Number
of Options
|
|||||
|
Outstanding,
February 28, 2009
|
$2.00-3.00
|
$0.00
|
1,913,000
|
||||
|
Issued
|
$1.50
|
$0.00
|
6,915,500
|
||||
|
Cancelled
|
$2.00-3.00
|
(1,913,000)
|
|||||
|
Outstanding,
November 30, 2009
|
$1.50
|
$0.00
|
6,915,500
|
||||
|
Options
Outstanding
|
Exercisable
Options
|
||||||||||||||||||
|
Range
of Exercise
Price
|
Number
|
Weighted
Average Remaining Life
|
Weighted
Average Exercise Price
|
Weighted
Average Remaining Life
|
Number
|
Weighted
Average Exercise Price
|
|||||||||||||
|
$1.50
|
6,915,500
|
4.50
years
|
$
|
1.50
|
4.50
years
|
6,110,615
|
$
|
1.50
|
|||||||||||
|
Number
of Shares
|
Exercise
Prices
|
|
|
Outstanding,
February 28, 2009
|
3,452,511
|
$2.00-4.00
|
|
Issued
|
3,185,996
|
$1.25-1.50
|
|
Exercised
|
(94,428)
|
$1.00
|
|
Outstanding,
November 30, 2009
|
6,544,079
|
$1.25-4.00
|
|
Range
of Exercise Prices
|
Stock
Warrants Outstanding
|
Stock
Warrants Exercisable
|
Weighted-Average
Remaining Contractual Life
|
Weighted-Average
Exercise Price of Warrants Outstanding
|
Weighted-Average
Exercise Price of Warrants Exercisable
|
Intrinsic
Value
|
||||||
|
$1.25
|
1,285,996
|
1,285,996
|
56
months
|
$1.25
|
$1.25
|
$0.00
|
||||||
|
$1.50
|
1,900,000
|
1,900,000
|
55
months
|
$1.50
|
$1.50
|
$0.00
|
||||||
|
$2.00-$3.00
|
1,934,991
|
1,782,908
|
15
months
|
$2.44
|
$2.49
|
$0.00
|
||||||
|
$3.50
|
805,589
|
805,589
|
25months
|
$3.50
|
$3.50
|
$0.00
|
||||||
|
$4.00
|
617,503
|
617,503
|
14
months
|
$4.00
|
$4.00
|
$0.00
|
||||||
|
6,544,079
|
6,391,996
|
|
2009
|
2008
|
|||||||
|
United
States
|
$
|
1,737,148
|
$
|
1,201,522
|
||||
|
Canada
|
231,849
|
253,930
|
||||||
|
Asia
|
439,495
|
429,566
|
||||||
|
Europe
|
16,891
|
6,139
|
||||||
|
Total
|
$
|
2,425,383
|
$
|
1,891,157
|
||||
|
11)
|
Subsequent
Events
|
|
·
|
Our
ability to generate positive cash flow from
operations;
|
|
·
|
Our
ability to obtain additional financing to fund our
operations;
|
|
·
|
Our
business development and operating development;
and
|
|
·
|
Our
expectations of growth in demand for our
products.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|